UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation

Clinical and experimental allergy, 2012-06, Vol.42 (6), p.946-957

2012

Volltextzugriff (PDF)

3065 A phase II study of chemotherapy combined with bevacizumab for patients with malignant pleural effusions: North East Japan Lung Cancer Study Group Trial NEJ013A

European journal of cancer (1990), 2015-09, Vol.51, p.S618-S618

2015

Volltextzugriff (PDF)

A prostacyclin agonist with thromboxane inhibitory activity for airway allergic inflammation in mice

Clinical and experimental allergy, 2010-02, Vol.40 (2), p.317-326

2010

Volltextzugriff (PDF)

EP08.03-02 Nivolumab Plus Ipilimumab in Relapsed Stage III Non-Small Cell Lung Cancer After Durvalumab Following Chemoradiotherapy

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S589

2023

Volltextzugriff (PDF)

1108 POSTER DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 3, X-linked is a CD133+ Tumour-specific Protein and Induces Antitumour Immunity

European journal of cancer (1990), 2011, Vol.47, p.S126-S127

2011

Volltextzugriff (PDF)

9087 POSTER Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy

European journal of cancer (1990), 2011, Vol.47, p.S618-S619

2011

Volltextzugriff (PDF)

1067P Discovery of a new CD4+ T cell cluster that correlates PD-1 blockade efficacy

Annals of oncology, 2022-09, Vol.33, p.S1041-S1042

2022

Volltextzugriff (PDF)

1292MO A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (≧75 years): NEJ039A

Annals of oncology, 2023-10, Vol.34, p.S745-S746

2023

Volltextzugriff (PDF)

Appropriate Timing of CD40 Ligation for RNA-Pulsed DCs to Induce Antitumor Immunity

Scandinavian journal of immunology, 2008-04, Vol.67 (4), p.385-391

2008

Volltextzugriff (PDF)

Immunological impact of surgery in NSCLC patients

Annals of oncology, 2019-10, Vol.30, p.v587

2019

Volltextzugriff (PDF)

1446P - Immunological impact of surgery in NSCLC patients

Annals of oncology, 2019-10, Vol.30, p.v587-v587

2019

Volltextzugriff (PDF)

568P First-line (1L) osimertinib + platinum-pemetrexed in EGFR-mutated (EGFRm) advanced NSCLC: Updated FLAURA2 safety run-in (SRI) results

Annals of oncology, 2023-11, Vol.34, p.S1692-S1693

2023

Volltextzugriff (PDF)

Effector CD4+ T-cell induction by thoracic radiotherapy for patients with NSCLC

Annals of oncology, 2019-10, Vol.30, p.v596

2019

Volltextzugriff (PDF)

1468P - Effector CD4+ T-cell induction by thoracic radiotherapy for patients with NSCLC

Annals of oncology, 2019-10, Vol.30, p.v596-v596

2019

Volltextzugriff (PDF)

A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy

Japanese journal of clinical oncology, 2019-02, Vol.49 (2), p.121-129

2019

Volltextzugriff (PDF)

CD40 Ligand Promotes Priming of Fully Potent Antitumor CD4+ T Cells in Draining Lymph Nodes in the Presence of Apoptotic Tumor Cells

The Journal of immunology (1950), 2001-11, Vol.167 (10), p.5678-5688

2001

Volltextzugriff (PDF)

Generation of Anti-tumour Effector T Cells from Naïve T Cells by Stimulation with Dendritic/tumour Fusion Cells

Scandinavian journal of immunology, 2007-11, Vol.66 (5), p.546-554

2007

Volltextzugriff (PDF)

Phase I II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer

British journal of cancer, 2003-09, Vol.89 (5), p.803-807

2003

Volltextzugriff (PDF)

Anti-cytokine autoantibodies are ubiquitous in healthy individuals

FEBS letters, 2007-05, Vol.581 (10), p.2017-2021

2007

Volltextzugriff (PDF)

Phase II study to evaluate the peripheral blood mononuclear cell biomarker for nivolumab efficacy on previously treated non-small cell lung cancer subjects (NEJ029B: IMMUNITY-ONE)

Annals of oncology, 2019-10, Vol.30, p.v617-v618

2019

Volltextzugriff (PDF)

1504P - Phase II study to evaluate the peripheral blood mononuclear cell biomarker for nivolumab efficacy on previously treated non-small cell lung cancer subjects (NEJ029B: IMMUNITY-ONE)

Annals of oncology, 2019-10, Vol.30, p.v617-v618

2019

Volltextzugriff (PDF)

Successful liquid storage of peripheral blood stem cells at subzero non-freezing temperature

Bone marrow transplantation (Basingstoke), 2002-12, Vol.30 (11), p.777-784

2002

Volltextzugriff (PDF)

P3.01-90 A Phase II Study Evaluating Continuation of EGFR-TKIs Beyond Progressive Disease Followed by the Addition of CDDP+PEM+Bev

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S901-S901

2018

Volltextzugriff (PDF)

A21 GENETIC REGULATION OF CHRONIC AIRWAY INFLAMMATION: Assessment Of Predisposing Factors To Decline In Lung Function In Patients With Bronchial Asthma

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

Both Regulatory T Cells and Antitumor Effector T Cells Are Primed in the Same Draining Lymph Nodes during Tumor Progression

The Journal of immunology (1950), 2005-10, Vol.175 (8), p.5058-5066

2005

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(58)
Berichte
(1)

Sprache

Englisch
(58)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Female
(17)
Animals
(13)
Immunology
(13)
Humans
(11)
Mice
(11)
Mice, Inbred C57bl
(9)
Male
(8)
Lymph Nodes - Immunology
(7)
Middle Aged
(7)
Biological And Medical Sciences
(6)
Cells, Cultured
(5)
Dendritic Cells - Immunology
(5)
Hematology, Oncology And Palliative Medicine
(5)
Medical Sciences
(5)
Adult
(4)
Aged
(4)
Biophysics
(4)
Cd4-Positive T-Lymphocytes - Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation

3065 A phase II study of chemotherapy combined with bevacizumab for patients with malignant pleural effusions: North East Japan Lung Cancer Study Group Trial NEJ013A

A prostacyclin agonist with thromboxane inhibitory activity for airway allergic inflammation in mice

EP08.03-02 Nivolumab Plus Ipilimumab in Relapsed Stage III Non-Small Cell Lung Cancer After Durvalumab Following Chemoradiotherapy

1108 POSTER DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 3, X-linked is a CD133+ Tumour-specific Protein and Induces Antitumour Immunity

9087 POSTER Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy

1067P Discovery of a new CD4+ T cell cluster that correlates PD-1 blockade efficacy

1292MO A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (≧75 years): NEJ039A

Appropriate Timing of CD40 Ligation for RNA-Pulsed DCs to Induce Antitumor Immunity

Immunological impact of surgery in NSCLC patients

1446P - Immunological impact of surgery in NSCLC patients

568P First-line (1L) osimertinib + platinum-pemetrexed in EGFR-mutated (EGFRm) advanced NSCLC: Updated FLAURA2 safety run-in (SRI) results

Effector CD4+ T-cell induction by thoracic radiotherapy for patients with NSCLC

1468P - Effector CD4+ T-cell induction by thoracic radiotherapy for patients with NSCLC

A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy

CD40 Ligand Promotes Priming of Fully Potent Antitumor CD4+ T Cells in Draining Lymph Nodes in the Presence of Apoptotic Tumor Cells

Generation of Anti-tumour Effector T Cells from Naïve T Cells by Stimulation with Dendritic/tumour Fusion Cells

Phase I II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer

Anti-cytokine autoantibodies are ubiquitous in healthy individuals

Phase II study to evaluate the peripheral blood mononuclear cell biomarker for nivolumab efficacy on previously treated non-small cell lung cancer subjects (NEJ029B: IMMUNITY-ONE)

1504P - Phase II study to evaluate the peripheral blood mononuclear cell biomarker for nivolumab efficacy on previously treated non-small cell lung cancer subjects (NEJ029B: IMMUNITY-ONE)

Successful liquid storage of peripheral blood stem cells at subzero non-freezing temperature

P3.01-90 A Phase II Study Evaluating Continuation of EGFR-TKIs Beyond Progressive Disease Followed by the Addition of CDDP+PEM+Bev

A21 GENETIC REGULATION OF CHRONIC AIRWAY INFLAMMATION: Assessment Of Predisposing Factors To Decline In Lung Function In Patients With Bronchial Asthma

Both Regulatory T Cells and Antitumor Effector T Cells Are Primed in the Same Draining Lymph Nodes during Tumor Progression

Suchergebnisse filtern